Investigational Amgen Drug Slashed Cholesterol By 81 Percent

Apr. 20 | Amgen announced about the positive results from a Phase 1b clinical study of AMG 145, an investigational PCSK9 inhibitor, in patients with high cholesterol who were taking statins. The study demonstrated that multiple doses of AMG 145 significantly reduced...